Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells
Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potentia...
Gespeichert in:
Veröffentlicht in: | Journal of neuroimmunology 2015-09, Vol.286, p.5-12 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 12 |
---|---|
container_issue | |
container_start_page | 5 |
container_title | Journal of neuroimmunology |
container_volume | 286 |
creator | Taka, Equar Mazzio, Elizabeth A Goodman, Carl B Redmon, Natalie Flores-Rozas, Hernan Reams, Renee Darling-Reed, Selina Soliman, Karam F.A |
description | Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin > MIP-1alpha > MIP-1 g > IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells. |
doi_str_mv | 10.1016/j.jneuroim.2015.06.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1727674089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S016557281500168X</els_id><sourcerecordid>1706576002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</originalsourceid><addsrcrecordid>eNqNkUtv1TAQRi0EoreFv1BlySbB78cGUSqgSFdiwUPsLF9nAg6JXeyk0v33OLotCzawms2ZmW_OIHRJcEcwkS_Hboyw5hTmjmIiOiw7TMgjtCNa0VZzSh6jXQVFKxTVZ-i8lBFXkHHzFJ1RSY1mRO_Q_iouoQ1xmNw8uyXlYwPDAH4pTRqa5cdxTr_WEFOEJsTG-SXcuQX65s3XljZz8Dl9n4KbGg_TVJ6hJ4ObCjy_rxfoy7u3n69v2v3H9x-ur_atF5gvLReSC9-bQy1KGjVwIdwA5gBc04PrFZNM8N4wro2QTIExNbnpgVGnsAR2gV6c5t7mmg7KYudQtgQuQlqLJYoqqTjW5j9QLGsIjGlF5QmtR5WSYbC3OcwuHy3BdpNuR_sg3W7SLZa2Sq-Nl_c71sMM_Z-2B8sVeH0CoEq5C5Bt8QGihz7kqtr2Kfx7x6u_RvgpxODd9BOOUMa05liVW2ILtdh-2l6_fZ6I-nWpv7HfiMeqCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706576002</pqid></control><display><type>article</type><title>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Taka, Equar ; Mazzio, Elizabeth A ; Goodman, Carl B ; Redmon, Natalie ; Flores-Rozas, Hernan ; Reams, Renee ; Darling-Reed, Selina ; Soliman, Karam F.A</creator><creatorcontrib>Taka, Equar ; Mazzio, Elizabeth A ; Goodman, Carl B ; Redmon, Natalie ; Flores-Rozas, Hernan ; Reams, Renee ; Darling-Reed, Selina ; Soliman, Karam F.A</creatorcontrib><description>Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin > MIP-1alpha > MIP-1 g > IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/j.jneuroim.2015.06.011</identifier><identifier>PMID: 26298318</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Allergy and Immunology ; Animals ; Anti-Inflammatory Agents - pharmacology ; Benzoquinones - pharmacology ; Black cumin seed ; Cell Line, Transformed ; Cell Survival - drug effects ; Cytokines ; Cytokines - genetics ; Cytokines - metabolism ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - pharmacology ; Enzyme-Linked Immunosorbent Assay ; Gene Expression Regulation - drug effects ; Lipopolysaccharides - pharmacology ; Lysine - analogs & derivatives ; Lysine - pharmacology ; Mice ; Microglia - drug effects ; Microglia - metabolism ; Microglial cells, Parkinson's, neurodegeneration ; Neurology ; Nigella sativa ; Nitric oxide ; Nitric Oxide Synthase Type II - metabolism ; Nitrites - metabolism ; RNA, Messenger - metabolism ; Thymoquinone</subject><ispartof>Journal of neuroimmunology, 2015-09, Vol.286, p.5-12</ispartof><rights>Elsevier B.V.</rights><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</citedby><cites>FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jneuroim.2015.06.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26298318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taka, Equar</creatorcontrib><creatorcontrib>Mazzio, Elizabeth A</creatorcontrib><creatorcontrib>Goodman, Carl B</creatorcontrib><creatorcontrib>Redmon, Natalie</creatorcontrib><creatorcontrib>Flores-Rozas, Hernan</creatorcontrib><creatorcontrib>Reams, Renee</creatorcontrib><creatorcontrib>Darling-Reed, Selina</creatorcontrib><creatorcontrib>Soliman, Karam F.A</creatorcontrib><title>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</title><title>Journal of neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><description>Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin > MIP-1alpha > MIP-1 g > IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Benzoquinones - pharmacology</subject><subject>Black cumin seed</subject><subject>Cell Line, Transformed</subject><subject>Cell Survival - drug effects</subject><subject>Cytokines</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lysine - analogs & derivatives</subject><subject>Lysine - pharmacology</subject><subject>Mice</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>Microglial cells, Parkinson's, neurodegeneration</subject><subject>Neurology</subject><subject>Nigella sativa</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Nitrites - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Thymoquinone</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1TAQRi0EoreFv1BlySbB78cGUSqgSFdiwUPsLF9nAg6JXeyk0v33OLotCzawms2ZmW_OIHRJcEcwkS_Hboyw5hTmjmIiOiw7TMgjtCNa0VZzSh6jXQVFKxTVZ-i8lBFXkHHzFJ1RSY1mRO_Q_iouoQ1xmNw8uyXlYwPDAH4pTRqa5cdxTr_WEFOEJsTG-SXcuQX65s3XljZz8Dl9n4KbGg_TVJ6hJ4ObCjy_rxfoy7u3n69v2v3H9x-ur_atF5gvLReSC9-bQy1KGjVwIdwA5gBc04PrFZNM8N4wro2QTIExNbnpgVGnsAR2gV6c5t7mmg7KYudQtgQuQlqLJYoqqTjW5j9QLGsIjGlF5QmtR5WSYbC3OcwuHy3BdpNuR_sg3W7SLZa2Sq-Nl_c71sMM_Z-2B8sVeH0CoEq5C5Bt8QGihz7kqtr2Kfx7x6u_RvgpxODd9BOOUMa05liVW2ILtdh-2l6_fZ6I-nWpv7HfiMeqCQ</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>Taka, Equar</creator><creator>Mazzio, Elizabeth A</creator><creator>Goodman, Carl B</creator><creator>Redmon, Natalie</creator><creator>Flores-Rozas, Hernan</creator><creator>Reams, Renee</creator><creator>Darling-Reed, Selina</creator><creator>Soliman, Karam F.A</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope></search><sort><creationdate>20150915</creationdate><title>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</title><author>Taka, Equar ; Mazzio, Elizabeth A ; Goodman, Carl B ; Redmon, Natalie ; Flores-Rozas, Hernan ; Reams, Renee ; Darling-Reed, Selina ; Soliman, Karam F.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Benzoquinones - pharmacology</topic><topic>Black cumin seed</topic><topic>Cell Line, Transformed</topic><topic>Cell Survival - drug effects</topic><topic>Cytokines</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lysine - analogs & derivatives</topic><topic>Lysine - pharmacology</topic><topic>Mice</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>Microglial cells, Parkinson's, neurodegeneration</topic><topic>Neurology</topic><topic>Nigella sativa</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Nitrites - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Thymoquinone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taka, Equar</creatorcontrib><creatorcontrib>Mazzio, Elizabeth A</creatorcontrib><creatorcontrib>Goodman, Carl B</creatorcontrib><creatorcontrib>Redmon, Natalie</creatorcontrib><creatorcontrib>Flores-Rozas, Hernan</creatorcontrib><creatorcontrib>Reams, Renee</creatorcontrib><creatorcontrib>Darling-Reed, Selina</creatorcontrib><creatorcontrib>Soliman, Karam F.A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taka, Equar</au><au>Mazzio, Elizabeth A</au><au>Goodman, Carl B</au><au>Redmon, Natalie</au><au>Flores-Rozas, Hernan</au><au>Reams, Renee</au><au>Darling-Reed, Selina</au><au>Soliman, Karam F.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</atitle><jtitle>Journal of neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>2015-09-15</date><risdate>2015</risdate><volume>286</volume><spage>5</spage><epage>12</epage><pages>5-12</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin > MIP-1alpha > MIP-1 g > IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26298318</pmid><doi>10.1016/j.jneuroim.2015.06.011</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-5728 |
ispartof | Journal of neuroimmunology, 2015-09, Vol.286, p.5-12 |
issn | 0165-5728 1872-8421 |
language | eng |
recordid | cdi_proquest_miscellaneous_1727674089 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Allergy and Immunology Animals Anti-Inflammatory Agents - pharmacology Benzoquinones - pharmacology Black cumin seed Cell Line, Transformed Cell Survival - drug effects Cytokines Cytokines - genetics Cytokines - metabolism Dose-Response Relationship, Drug Enzyme Inhibitors - pharmacology Enzyme-Linked Immunosorbent Assay Gene Expression Regulation - drug effects Lipopolysaccharides - pharmacology Lysine - analogs & derivatives Lysine - pharmacology Mice Microglia - drug effects Microglia - metabolism Microglial cells, Parkinson's, neurodegeneration Neurology Nigella sativa Nitric oxide Nitric Oxide Synthase Type II - metabolism Nitrites - metabolism RNA, Messenger - metabolism Thymoquinone |
title | Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A45%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-inflammatory%20effects%20of%20thymoquinone%20in%20activated%20BV-2%20microglial%20cells&rft.jtitle=Journal%20of%20neuroimmunology&rft.au=Taka,%20Equar&rft.date=2015-09-15&rft.volume=286&rft.spage=5&rft.epage=12&rft.pages=5-12&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/j.jneuroim.2015.06.011&rft_dat=%3Cproquest_cross%3E1706576002%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706576002&rft_id=info:pmid/26298318&rft_els_id=1_s2_0_S016557281500168X&rfr_iscdi=true |